Inventor · disambiguated record
Gordon Powers
Also filed as: POWERS GORDON · POWERS GORDON D · POWERS GORDON DONALD
23 granted patents·8 pending applications·240 citations·filing 2000–2025
96Inventor score
Files withJANSSEN PHARMACEUTICA NV10IMMUNEXT INC8JANSSEN BIOTECH INC4GREIG NIGEL H3MESSAGE PHARMACEUTICALS3
Top patents by PatentIndex Score
31 records- 0195US12188938B2Anti-VISTA antibodies and fragmentsJANSSEN PHARMACEUTICA NV·Filed 2021·Granted Jan 7, 2025·4 cites·18 claims
- 0295US11987630B2Anti-vista antibodies and fragments, uses thereof, and methods of identifying sameJANSSEN PHARMACEUTICA NV·Filed 2020·Granted May 21, 2024·4 cites·2 claims
- 0395US10072088B2Anti-BCMA antibodies and uses thereofJANSSEN PHARMACEUTICA NV·Filed 2016·Granted Sep 11, 2018·30 cites·16 claims
- 0493US12139532B2Anti-human vista antibodies and use thereofIMMUNEXT INC·Filed 2017·Granted Nov 12, 2024·4 cites·14 claims
- 0593US11242392B2Anti-vista antibodies and fragmentsJANSSEN PHARMACEUTICA NV·Filed 2019·Granted Feb 8, 2022·4 cites·32 claims
- 0693US11009509B2Anti-VISTA antibodies and fragmentsJANSSEN PHARMACEUTICA NV·Filed 2016·Granted May 18, 2021·7 cites·26 claims
- 0793US8691864B2Agents useful for reducing amyloid precursor protein and treating dementia and methods of use thereofGREIG NIGEL H·Filed 2012·Granted Apr 8, 2014·13 cites·25 claims
- 0893US8258172B2Agents useful for reducing amyloid precursor protein and treating dementia and methods of use thereofGREIG NIGEL H·Filed 2010·Granted Sep 4, 2012·11 cites·25 claims
- 0992US11603403B2Anti-human vista antibodies and use thereofIMMUNEXT INC·Filed 2017·Granted Mar 14, 2023·4 cites·11 claims
- 1092US11014987B2Anti-vista antibodies and fragments, uses thereof, and methods of identifying sameJANSSEN PHARMACEUTICA NV·Filed 2017·Granted May 25, 2021·9 cites·16 claims
- 1192US10899836B2Method of identifying anti-VISTA antibodiesJANSSEN PHARMACEUTICA NV·Filed 2017·Granted Jan 26, 2021·6 cites·5 claims
- 1291US11649283B2Anti-human vista antibodies and use thereofIMMUNEXT INC·Filed 2017·Granted May 16, 2023·4 cites·24 claims
- 1390US11603402B2Anti-human vista antibodies and use thereofIMMUNEXT INC·Filed 2017·Granted Mar 14, 2023·4 cites·9 claims
- 1490US7786162B2Agents useful for reducing amyloid precursor protein and treating dementia and methods of use thereofRAPTOR PHARMACEUTICAL CORP·Filed 2009·Granted Aug 31, 2010·11 cites·21 claims
- 1590US6630589B1Identification of compounds for the treatment or prevention of proliferative diseasesMESSAGE PHARMACEUTICALS·Filed 2002·Granted Oct 7, 2003·32 cites·34 claims
- 1690US2025263485A1Anti-human vista antibodies and use thereofIMMUNEXT INC·Filed 2024·Application pending·0 cites
- 1789US6936432B2Bacterial RNase P proteins and their use in identifying antibacterial compoundsMESSAGE PHARMACEUTICALS·Filed 2001·Granted Aug 30, 2005·37 cites·15 claims
- 1888US10894830B2Antibodies specifically binding PD-1, TIM-3 or PD-1 and TIM-3 and their usesJANSSEN BIOTECH INC·Filed 2016·Granted Jan 19, 2021·7 cites·21 claims
- 1987US11525000B2Anti-human VISTA antibodies and use thereofIMMUNEXT INC·Filed 2017·Granted Dec 13, 2022·4 cites·20 claims
- 2086US10273301B2Anti-vista antibodies and fragmentsJANSSEN PHARMACEUTICA NV·Filed 2014·Granted Apr 30, 2019·7 cites·44 claims
- 2186US7153882B2Agents useful for reducing amyloid precursor protein and treating demantia and methods of use thereofNAT INST OF HEALTH AND AXONYX·Filed 2001·Granted Dec 26, 2006·21 cites·157 claims
- 2284US2025354994A1Anti-vista antibodies and fragmentsJANSSEN PHARMACEUTICA NV·Filed 2024·Application pending·0 cites
- 2384US2025346666A1Anti-human vista antibodies and use thereofIMMUNEXT INC·Filed 2025·Application pending·0 cites
- 2483US6448007B1Functional genomic screen for post-transcriptional 5′ and 3′ regulatory elementsMESSAGE PHARMACEUTICALS·Filed 2000·Granted Sep 10, 2002·17 cites·33 claims
- 2583US2024067719A1Anti-human vista antibodies and use thereofIMMUNEXT INC·Filed 2022·Application pending·0 cites
- 2677US2025215079A1Antibodies specifically binding pd-1, tim-3 or pd-1 and tim-3 and their usesJANSSEN BIOTECH INC·Filed 2024·Application pending·0 cites
- 2768US12441801B2Anti-VISTA antibodies and fragments, uses thereof, and methods of identifying sameJANSSEN PHARMACEUTICA NV·Filed 2021·Granted Oct 14, 2025·0 cites·12 claims
- 2867US12173064B2Antibodies specifically binding PD-1, TIM-3 or PD-1 and TIM-3 and their usesJANSSEN BIOTECH INC·Filed 2020·Granted Dec 24, 2024·0 cites·30 claims
- 2967US2006270729A1Agents useful for reducing amylioid precursor protein and treating dementia and methods of use thereofGREIG NIGEL H·Filed 2006·Application pending·0 cites
- 3056US2024025992A1Proteins comprising delta-like ligand 3 (dll3) antigen binding domains and their usesJANSSEN BIOTECH INC·Filed 2021·Application pending·0 cites
- 3141US2005187409A1Inhibitors of RNase P proteins as antibacterial compoundsFiled 2004·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Gordon Powers files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →